Vienet R - Search Results

1

Metabolite involvement in bromocriptine-induced prolactin inhibition in rats.

Valente D, Delaforge M, Urien S, Guivarc'h D, Vienet R, Grognet JM, Ezan E. Valente D, et al. Among authors: vienet r. J Pharmacol Exp Ther. 1997 Sep;282(3):1418-24. J Pharmacol Exp Ther. 1997. PMID: 9316855

2

Effect of chronic converting-enzyme inhibition on kidney function of senescent hypertensive rats.

Vienet R, Grognet JM, Ezan E, Lecaque D, Hamon G, Corman B. Vienet R, et al. J Cardiovasc Pharmacol. 1994;23 Suppl 4:S19-25. J Cardiovasc Pharmacol. 1994. PMID: 7527097

3

Pharmacokinetic analysis of 6-monoamino-beta-cyclodextrin after intravenous or oral administration to rats using a specific enzyme immunoassay.

Créminon C, Djedaïni-Pilard F, Vienet R, Péan C, Grognet JM, Grassi J, Perly B, Pradelles P. Créminon C, et al. Among authors: vienet r. J Pharm Sci. 1999 Mar;88(3):302-5. doi: 10.1021/js9802998. J Pharm Sci. 1999. PMID: 10052987

4

Development and in vivo assessment of a transdermal system for physostigmine.

Benech H, Vincenti M, Fouchart F, Pruvost A, Vienet R, Istin M, Grognet JM. Benech H, et al. Among authors: vienet r. Methods Find Exp Clin Pharmacol. 1998 Jul-Aug;20(6):489-98. doi: 10.1358/mf.1998.20.6.485712. Methods Find Exp Clin Pharmacol. 1998. PMID: 9789873 Free article.

5

A new specific enzyme immunoassay allowing an efficient pharmacokinetic evaluation of gamma-cyclodextrin after intravenous administration to rats.

Créminon C, Djedaïni-Pilard F, Vienet R, Péan C, Grognet JM, Grassi J, Perly B, Pradelles P. Créminon C, et al. Among authors: vienet r. Pharm Res. 1999 Sep;16(9):1407-11. doi: 10.1023/a:1018903109564. Pharm Res. 1999. PMID: 10496657

6

Targets for SMR1-pentapeptide suggest a link between the circulating peptide and mineral transport.

Rougeot C, Vienet R, Cardona A, Le Doledec L, Grognet JM, Rougeon F. Rougeot C, et al. Among authors: vienet r. Am J Physiol. 1997 Oct;273(4):R1309-20. doi: 10.1152/ajpregu.1997.273.4.R1309. Am J Physiol. 1997. PMID: 9362294

7

The anti-HIV pentameric pseudopeptide HB-19 is preferentially taken up in vivo by lymphoid organs where it forms a complex with nucleolin.

Krust B, Vienet R, Cardona A, Rougeot C, Jacotot E, Callebaut C, Guichard G, Briand JP, Grognet JM, Hovanessian AG, Edelman L. Krust B, et al. Among authors: vienet r. Proc Natl Acad Sci U S A. 2001 Nov 20;98(24):14090-5. doi: 10.1073/pnas.221467298. Epub 2001 Nov 6. Proc Natl Acad Sci U S A. 2001. PMID: 11698640 Free PMC article.

8

Pharmacokinetic, metabolic, and antidiarrheal properties of (D and L) heptapeptides of sorbin in rodent.

Nicol P, Vienet R, Jourdan G, Dumas C, Abou el Fadil F, Benech H, Grognet JM, Tarrade T, Pansu D, Descroix-Vagne M. Nicol P, et al. Among authors: vienet r. Peptides. 1995;16(8):1343-50. doi: 10.1016/0196-9781(95)02045-4. Peptides. 1995. PMID: 8745042

9

In vivo involvement of heparan sulfate proteoglycan in the bioavailability, internalization, and catabolism of exogenous basic fibroblast growth factor.

Colin S, Jeanny JC, Mascarelli F, Vienet R, Al-Mahmood S, Courtois Y, Labarre J. Colin S, et al. Among authors: vienet r. Mol Pharmacol. 1999 Jan;55(1):74-82. doi: 10.1124/mol.55.1.74. Mol Pharmacol. 1999. PMID: 9882700

10

Converting enzyme inhibition prevents postprandial hyperfiltration in rats with renal mass ablation.

Corman B, Vienet R. Corman B, et al. Among authors: vienet r. Am J Hypertens. 1991 Mar;4(3 Pt 2):253S-257S. doi: 10.1093/ajh/4.3.253s. Am J Hypertens. 1991. PMID: 2043314

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13 results

Search Page

Filters